• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Genet Evol . Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia

tetano

Editor, Senior Moderator
Infect Genet Evol


. 2021 Dec 18;105192.
doi: 10.1016/j.meegid.2021.105192. Online ahead of print.
Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia


Jubby Marcela Gálvez Bermúdez[SUP] 1 [/SUP], Henry Mauricio Chaparro-Solano[SUP] 2 [/SUP], Ángela María Pinzón-Rondón[SUP] 3 [/SUP], Ludwig L Albornoz[SUP] 4 [/SUP], Juan Mauricio Pardo-Oviedo[SUP] 3 [/SUP], Fabio Andrés Zapata-Gómez[SUP] 1 [/SUP], Andrés Felipe Patiño-Aldana[SUP] 3 [/SUP], Andrea Del Pilar Hernández-Rodríguez[SUP] 5 [/SUP], Mateo Díaz-Quiroz[SUP] 5 [/SUP], Ángela María Ruiz-Sternberg[SUP] 6 [/SUP]



Affiliations

Abstract

The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is the etiopathogenic agent of COVID-19, a condition that has led to a formally recognized pandemic by March 2020 (World Health Organization -WHO). The SARS-CoV-2 genome is constituted of 29,903 base pairs, that code for four structural proteins (N, M, S, and E) and more than 20 non-structural proteins. Mutations in any of these regions, especially in those that encode for the structural proteins, have allowed the identification of diverse lineages around the world, some of them named as Variants of Concern (VOC) and Variants of Interest (VOI), according to the WHO and CDC. In this study, by using Next Generation Sequencing (NGS) technology, we sequenced the SARS-CoV-2 genome of 422 samples from Colombian residents, all of them collected between April 2020 and January 2021. We obtained genetic information from 386 samples, leading us to the identification of 14 new lineages circulating in Colombia, 13 of which were identified for the first time in South America. GH was the predominant GISAID clade in our sample. Most mutations were either missense (53.6%) or synonymous mutations (37.4%), and most genetic changes were located in the ORF1ab gene (63.9%), followed by the S gene (12.9%). In the latter, we identified mutations E484K, L18F, and D614G. Recent evidence suggests that these mutations concede important particularities to the virus, compromising host immunity, the diagnostic test performance, and the effectiveness of some vaccines. Some important lineages containing these mutations are the Alpha, Beta, and Gamma (WHO Label). Further genomic surveillance is important for the understanding of emerging genomic variants and their correlation with disease severity.

Keywords: Covid-19; Genetic variation; High-throughput nucleotide sequencing; SARS-CoV-2; SARS-CoV-2 variants; Whole genome sequencing.
 
Back
Top Bottom